On Jan. 28, major orthopedic and spine device manufacturer Stryker announced plans to sell off its U.S. spinal implants business. Here are eight things for ASCs to know about the sale: 1. Stryker's ...

Wall Street analysts rerated Stryker Corp (NYSE:SYK) Wednesday after the company’s fourth-quarter print. Stryker reported quarterly earnings of $4.01 per share, which beat the analyst consensus ...